As of November 6, 2026, NEUROONE MEDICAL TECHNOLOGIES Corp is a publicly traded company (Nasdaq: NMTC); its largest reported holder is Bleichroeder LP, with 8.03% on Schedule 13G of August 14, 2025. The largest insider holding is Brian Pratt, a 10% owner, with 1,085,934 shares (11.9% of shares outstanding), per Form 3 of July 14, 2026 (Schedule 13G, August 14, 2025).
Is this your company?
About to sign with, pay or invest in NEUROONE MEDICAL TECHNOLOGIES Corp? See the free Snapshot first.
Free to see. No signup.
Is NEUROONE MEDICAL TECHNOLOGIES Corp a real, registered company?
- NeuroOne Medical Technologies Corporation files with the SEC under CIK 1500198 (its SEC filings).
- Its shares are listed under the ticker NMTC on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Eden Prairie, Minnesota, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under NEUROONE MEDICAL TECHNOLOGIES Corp in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Ronald McClurg, Chief Financial Officer (Form 8-K filed 2026-04-30). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Brian Pratt (filed 2026-07-14).
Who are NEUROONE MEDICAL TECHNOLOGIES Corp's owners and officers?
NEUROONE MEDICAL TECHNOLOGIES Corp: incorporated in Delaware; business address in Eden Prairie, Minnesota; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-07-14).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2024-08-16)
- : Executive Officer (Form D, 2024-08-16)
- : Executive Officer (Form D, 2024-08-16)
- : Executive Officer (Form D, 2024-08-16)
- : Executive Officer (Form D, 2024-08-16)
- : Director (Form D, 2024-08-16)
- : Director (Form D, 2024-08-16)
- : Director (Form D, 2024-08-16)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-14 | Brian Pratt | 12.5% |
| Schedule 13G, 2026-04-21 | Brian Pratt | 7.4% |
| Schedule 13G/A, 2025-11-12 | Sio Capital Management, LLC | 4.72% |
| Schedule 13G, 2025-08-14 | Bleichroeder LP | 8.03% |
| Schedule 13G, 2025-08-13 | Sio Capital Management, LLC | 7.07% |
Questions about who owns NEUROONE MEDICAL TECHNOLOGIES Corp
Who owns NEUROONE MEDICAL TECHNOLOGIES Corp?
On this page, 2 holders' latest ownership filings report 5% or more of NEUROONE MEDICAL TECHNOLOGIES Corp: Brian Pratt (12.5%, Schedule 13G/A, filed 2026-07-14) and Bleichroeder LP (8.03%, Schedule 13G, filed 2025-08-14).
Who are the largest shareholders of NEUROONE MEDICAL TECHNOLOGIES Corp?
By the share each holder's latest filing reports, the largest holders of NEUROONE MEDICAL TECHNOLOGIES Corp on this page are Brian Pratt (12.5%) and Bleichroeder LP (8.03%).
When did Brian Pratt buy into NEUROONE MEDICAL TECHNOLOGIES Corp?
The filings give report dates, not purchase dates. The earliest filing from Brian Pratt on this page is the Schedule 13G, filed 2026-04-21, reporting 7.4%; its latest, Schedule 13G/A filed 2026-07-14, reports 12.5%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on NEUROONE MEDICAL TECHNOLOGIES Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on NEUROONE MEDICAL TECHNOLOGIES Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on NEUROONE MEDICAL TECHNOLOGIES Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-04-30 | Ronald McClurg | Chief Financial Officer | departed |
Which insiders own NEUROONE MEDICAL TECHNOLOGIES Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 1,085,934 shares (11.9% of shares outstanding) (Form 3, 2026-07-14).
- , the chief executive and president: 1,080,132 shares (11.9% of shares outstanding) (Form 4, 2026-04-01).
- , the chief financial officer: 444,117 shares (4.9% of shares outstanding) (Form 4, 2025-04-07).
- , the chief business officer: 199,999 shares (2.2% of shares outstanding) (Form 4, 2026-09-08).
- , a director: 178,733 shares (2.0% of shares outstanding) (Form 4, 2026-04-07).
Shares outstanding: 9,105,763 as of 2026-08-11, from the company's latest SEC cover page.
How much has NEUROONE MEDICAL TECHNOLOGIES Corp raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-08-16 | $276K | $276K |
Keep reading
More on NEUROONE MEDICAL TECHNOLOGIES Corp and the records around it.
NEUROONE MEDICAL TECHNOLOGIES Corp elsewhere on the record
- Leadership changes Apr 2026
Companies that share a holder
- Sio Capital Management, LLC also filed stake reports on 9 other companies: Enveric Biosciences, Inc. (Nov 2026), Adagio Medical Holdings, Inc. (Jul 2026), PMV Pharmaceuticals, Inc. (Jul 2026)
- Bleichroeder LP also filed stake reports on 16 other companies: MDxHealth SA (Oct 2026), Identiv, Inc. (INVE) (Aug 2026), Cellectar Biosciences, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/neuroone-medical-technologies